<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01788852</url>
  </required_header>
  <id_info>
    <org_study_id>HIV-NAT 139</org_study_id>
    <nct_id>NCT01788852</nct_id>
  </id_info>
  <brief_title>HPV in Adolescents</brief_title>
  <official_title>Prevalence of HPV and Intraepithelial Neoplasia Biomarkers in Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The HIV Netherlands Australia Thailand Research Collaboration</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thai Red Cross AIDS Research Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>South East Asia Research Collaboration with Hawaii</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>We Understand Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>TREAT Asia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The HIV Netherlands Australia Thailand Research Collaboration</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the prevalence of HPV infection in perinatally HIV-infected
      adolescents, intraepithelial neoplasia, and E6E7 biomarker at cervical and anal sites.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Human Papillomavirus (HPV) is the most common sexually transmitted disease and it causes
      cervical and anal cancer. Prevalence and incidence of HPV infection among young adults who
      are sexually experienced is high. No data exist for HIV-positive adolescents in regards to
      HPV infection, cervical and anal intraepithelial neoplasia. This study will compare the
      prevalence of HPV infection, intraepithelial neoplasia and E6/E7 biomarker at cervical and
      anal sites among perinatally HIV-infected adolescents, behaviorally HIV-infected adolescents,
      and HIV-negative adolescents.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HPV infection</measure>
    <time_frame>48 weeks</time_frame>
    <description>Prevalence of cervical and anal HPV infection and of oncogenic subtypes, among perinatally HIV-infected adolescents, behaviorally HIV-infected adolescents, and HIv-negative adolescents</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intraepithelial neoplasia</measure>
    <time_frame>48 weeks</time_frame>
    <description>Prevalence of intraepithelial neoplasia among the three study groups and in male and female subjects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E6/E7</measure>
    <time_frame>48 weeks</time_frame>
    <description>Prevalence of detected E6/E7 biomarker among the tree study groups and in male and female subjects.
Correlation between detected E6/E7 and presence of HPV infection and/or intraepithelial neoplasia Association between HAART use, CD4 counts, plasma HIV RNA level and HIV clinical staging with HPV infection, intraepithelial neoplasia and E6/E7 detection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HPV vaccine</measure>
    <time_frame>48 weeks</time_frame>
    <description>Proportion of adolescents who would benefit from the current preventive vaccine (i.e. those who have not been infected with oncogenic HPV subtypes 16 and 18)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">27</enrollment>
  <condition>HPV Infection</condition>
  <condition>Cervical/Anal Dysplasia</condition>
  <arm_group>
    <arm_group_label>Perinatally HIV-infected adolescents</arm_group_label>
    <description>Perinatally HIV-infected adolescents</description>
  </arm_group>
  <arm_group>
    <arm_group_label>behaviorally HIV-infected adolescents</arm_group_label>
    <description>behaviorally HIV-infected adolescents</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV negative adolescents</arm_group_label>
    <description>HIV negative adolescents</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cervical and anal pap smears specimens will be used for HPV typing. Blood will be collected
      for STI and immune response to HPV/HIV testing
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 60 sexually active adolescents (perinatally and behaviorally HIV-infected
        adolescents, HIV negative adolescents) aged 12-24 will be recruited from the HIV-NAT and
        TRC Anonymous Clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Perinatally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic acid
             testing (NAT) at any time and history of maternal HIV infection)

          -  behaviorally-infected (documented positive HIV enzyme immunoassay (EIA) or nucleic
             acid testing (NAT) at any time after sexual debut without history of maternal HIV
             infection)

          -  female with vaginal or receptive anal intercourse with a male OR male with receptive
             rectal intercourse with another male

          -  Signed informed consent. Volunteers aged 12-17 years can decide whether they wish for
             their parents to consent for their participation. Due to the confidential nature of
             the issues being studied, parental consent may be exempted

        Exclusion Criteria:

          -  Have any conditions that may interfer with subjects' ability to understand and consent
             to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jintanat Ananworanich, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The HIV Netherlands Australia Thailand Research Collaboration</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nittaya Phanuphak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thai Red Cross AIDS Research Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Pediatrics, Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HIV-NAT</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thai Red Cross - Anonymous Clinc</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>http://www.hivnat.org</url>
    <description>HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)'s website</description>
  </link>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2013</study_first_submitted>
  <study_first_submitted_qc>February 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2013</study_first_posted>
  <last_update_submitted>March 30, 2015</last_update_submitted>
  <last_update_submitted_qc>March 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HPV</keyword>
  <keyword>HIV</keyword>
  <keyword>cervical/anal dysplasia</keyword>
  <keyword>intraepithelial neoplasia</keyword>
  <keyword>E6/E7 biomarker</keyword>
  <keyword>perinatally HIV-infected adolescents</keyword>
  <keyword>behaviorally HIV-infected adolescents</keyword>
  <keyword>anal and pap smear</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Papillomavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

